I believe most investor sell it because it has no binary event until Q4 2016. And most of the investor do take profit after a huge ride in 2015. They will come back when the investment environment getting better.
Before FDA approval, EXAS was 15!
With the approval , it worth only 10?
Is the USPSTF rating more important than FDA approval?